NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
10.39
-0.03 (-0.29%)
At close: Jul 3, 2025, 1:00 PM
10.00
-0.39 (-3.75%)
After-hours: Jul 3, 2025, 1:32 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $340.78 million as of July 3, 2025. Its market cap has increased by 82.24% in one year.
Market Cap
340.78M
Enterprise Value
347.67M
1-Year Change
82.24%
Ranking
Category
Stock Price
$10.39
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $340.78M, a decrease of -13.35%. That is a compound annual growth rate of -3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 340.78M | 2.03% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |